Tapping into the biology of Alzheimer disease

Neurology

Volumn 76, Issue 6, 2011, Pages 496-497

  Knopman, David S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; PROTEIN PHOSPHO TAU181; TAU PROTEIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN SIZE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; DEMENTIA; EDITORIAL; EDUCATIONAL STATUS; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL;

EID: 79951670930     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820af995     Document Type: Editorial

References (10)

1. Roe CM, Fagan AM, Williams MM, et al. Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology 2011;76:501-510.
2. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Ce-rebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009; 65:403-413.
3. Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
4. Fagan AM, Head D, Shah AR, et al. Decreased cerebrospi-nal fluid Abeta(42) correlates with brain atrophy in cogni-tively normal elderly. Ann Neurol 2009;65:176-183.
5. Jack CR Jr, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009;132:1355-1365.
6. Ngandu T, von Strauss E, Helkala EL, et al. Education a (Pubitemid 47511466)
7. Kemppainen NM, Aalto S, Karrasch M, et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorode-oxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 2008; 63:112-118. (Pubitemid 351240557)
8. Garibotto V, Borroni B, Kalbe E, et al. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology 2008; 71:1342-1349.
9. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol 2008;65:113-120.
10. Borenstein Graves A, Mortimer JA, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology 2001;57:1453-1460. (Pubitemid 32995728)